Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness
暂无分享,去创建一个
H. Hackl | R. Wieser | J. Etzler | F. Grebien | H. Sill | G. Heller | C. Nguyen | D. Stoiber | Angela Schlerka | A. Grandits | E. Heyes